Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute intermittent porphyria

B Grandchamp1

  • 1INSERM U409, Faculté de Médecine Xavier Bichat, Paris, France.

Seminars in Liver Disease
|March 28, 1998
PubMed
Summary

Acute intermittent porphyria (AIP) is an autosomal dominant disorder affecting heme synthesis. DNA analysis aids in detecting presymptomatic carriers, improving genetic counseling and disease management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unexpected extradermatological findings in 31 patients with xeroderma pigmentosum type C.

The British journal of dermatology·2013
Same author

Intragenic rearrangements in LARGE and POMGNT1 genes in severe dystroglycanopathies.

Neuromuscular disorders : NMD·2011
Same author

EDNRB gene variants and melanoma risk in two southern European populations.

Clinical and experimental dermatology·2011
Same author

[Intra- and interfamilial phenotype variation in Birt-Hogg-Dubé syndrome: Consequences for therapy].

Annales de dermatologie et de venereologie·2010
Same author

Interactions between ultraviolet light exposure and DNA repair gene polymorphisms may increase melanoma risk.

The British journal of dermatology·2010
Same author

Xeroderma pigmentosum group C in a French Caucasian patient with multiple melanoma and unusual long-term survival.

The British journal of dermatology·2008

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Acute intermittent porphyria (AIP) is an autosomal dominant disorder with incomplete penetrance.
  • It is characterized by abdominal pain and neurological symptoms during acute attacks.
  • Biochemical abnormalities stem from defects in heme synthesis enzymes, leading to excess heme precursors.

Purpose of the Study:

  • To summarize the current understanding of Acute Intermittent Porphyria (AIP).
  • To highlight the role of genetic mutations in AIP pathogenesis.
  • To emphasize the diagnostic and counseling benefits of DNA analysis.

Main Methods:

  • Review of population studies on AIP prevalence.
  • Analysis of the genetic basis of AIP, focusing on the PBGD gene.
  • Discussion of diagnostic advancements, including DNA analysis.

Main Results:

  • Asymptomatic AIP heterozygotes may occur in 1 in 2,000 individuals.
  • Mutations in the porphobilinogen deaminase (PBGD) gene are identified.
  • DNA analysis enhances the accuracy of detecting presymptomatic heterozygotes.

Conclusions:

  • Understanding AIP pathophysiology is crucial for improved treatment.
  • Heme therapy has improved prognosis for acute attacks.
  • Genetic testing and DNA analysis are vital for early detection and management of AIP.

Related Experiment Videos